Chenxin Pharmaceuticals: Revenue in 2025 was 3.45 billion yuan, a year-on-year decrease of 13.48%.

Chenxin Pharmaceutical announced that in 2025, the company's revenue was 3.45 billion yuan, a year-on-year decrease of 13.48%; total profit was 496 million yuan, a year-on-year decrease of 13.82%; net profit attributable to owners of the parent company was 421 million yuan, a year-on-year decrease of 17.22%; net profit excluding non-recurring gains and losses was 256 million yuan, a year-on-year decrease of 39.82%. The total cash dividend distributed for the first half of 2025 and the full year of 2025 was 1.58 billion yuan, accounting for 37.40% of the net profit attributable to shareholders of the listed company for the year. The total research and development investment in 2025 was 286 million yuan, with over 100 ongoing projects.